Results 301 to 310 of about 98,994 (359)

OX40/OX40L modulation: A target for regulating T cells in cutaneous inflammatory disorders

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
OX40 and OX40L are a co‐stimulatory immune checkpoint pair. Modulation of this pair impacts multiple immune phenotypes and is an attractive target for immunotherapy in dermatological disorders. Trials are underway with the majority in atopic dermatitis and currently in phase 3 trials.
Aditya K. Gupta   +4 more
wiley   +1 more source

Trends in histological subtypes of cutaneous melanoma in the Netherlands from 1989 to 2023 - Influence of sunlight exposure and overdiagnosis. [PDF]

open access: yesTumori
van Niekerk CC   +6 more
europepmc   +1 more source

Aberrant Activation of the Hedgehog Pathway in Cutaneous Melanoma: Therapeutic Potential of Pharmacological Inhibitors. [PDF]

open access: yesInt J Mol Sci
Papaccio F   +9 more
europepmc   +1 more source

Prognostic Value of a Novel Nuclear Grading of Cutaneous Melanoma: The UNC Chapel Hill Method. [PDF]

open access: yesAm J Surg Pathol
McAlpine SG   +16 more
europepmc   +1 more source

Effect of Diuretics on Cutaneous Squamous Cell Carcinoma: Clinical and Translational Evidence

open access: yes
International Journal of Dermatology, EarlyView.
Kevin Sheng‐Kai Ma   +6 more
wiley   +1 more source

Supplementary data for "Genomics of primary and metastatic cutaneous melanoma: a systematic review and meta-analysis"

open access: green
Hoang Duc   +5 more
openalex   +1 more source

Home - About - Disclaimer - Privacy